Article

AI as a catalyst for mechanistic target discovery: Integrating systems pharmacology and multimodal data

2026-05-12

Abstract excerpt

Artificial intelligence (AI) is evolving from a predictive tool into a foundational computational infrastructure for mechanism-driven pharmacology, fundamentally reshaping drug discovery. This review examines how this transformation addresses persistent challenges in target validation, including data biases and the need for model interpretability, by integrating network pharmacology with advanced deep learning arc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ec34105c-4b56-5a25-be3a-3dd4dc1527c0
DOI: 10.22541/authorea.15003184/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

AI as a catalyst for mechanistic target discovery: Integrating systems pharmacology and multimodal dataDOI 10.22541/authorea.15003184/v1Read

Drug Discovery in the Era of Artificial Intelligence: From Target Identification to Clinical TrialsSemantic proximity Read

Artificial Intelligence Meets Drug Discovery: A Systematic Review on AI-Powered Target Identification and Molecular DesignSemantic proximity Read

Artificial Intelligence in Drug Discovery: A New Paradigm from Target Identification to Clinical TranslationSemantic proximity Read

Probabilistic graph-based model uncovers previously unseen druggable vulnerabilities in major solid cancersSemantic proximity Read

Connecting the dots: applications of network medicine in pharmacology and disease.Semantic proximity Read

Integrative Multi-Scale Network Simulation for Precision Drug Repurposing with PETSSemantic proximity Read

Encoding Drug-Target-Pathway-Disease profiles for Drug-Cancer Association Prediction using Graph Transformer-Convolution NetworksSemantic proximity Read

AI and Machine Learning in Biology: From Genes to ProteinsSemantic proximity Read

Multi-Modal Deep Learning Integrates Spatial Topologies and Sequential Motifs to Identify Class I HDAC Inhibitors as Pan-Cancer TherapeuticsSemantic proximity Read

OmniPert: A Deep Learning Foundation Model for Predicting Responses to Genetic and Chemical Perturbations in Single Cancer CellsSemantic proximity Read

An argument for mechanism-based statistical inference in cancer.Semantic proximity Read

Graph representation forecasting of patient’s medical conditions: towards a digital twinSemantic proximity Read